Home
Insights

Sinai Davis

VP, Global Head of Pharmacovigilance at AVEO Oncology

Sinai Davis, M.D. serves as Vice President, Global Head of Pharmacovigilance at AVEO Oncology. He brings more than 20 years of experience in drug and medical device safety. Dr. Davis started his career at the US Food & Drug Administration as a Consumer Safety Officer/Investigator at the NJ District Office in Parsippany, NJ. After 6 years at the agency, Dr. Davis took his experience and knowledge to industry and has been the Head of Safety at five pharma/biotech companies. He has experience in 10 therapeutic and three medical device areas and has been the drug safety physician on three successful NDAs. Dr. Davis has discovered two signals that required labeling changes including a Black Box Warning. He has built safety teams and developed systems, processes, and procedures to run successful pharmacovigilance departments. Dr. Davis received his B.S. Degree in Microbiology from The University of Alabama and his Medical Degree from C.E.U.X. School of Medicine.

Roles

  • VP, Global Head of Pharmacovigilance

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.